Gene: EFHC1
Official Full Name: EF-hand domain containing 1provided by HGNC
Gene Summary: This gene encodes an EF-hand-containing calcium binding protein. The encoded protein likely plays a role in calcium homeostasis. Mutations in this gene have been associated with susceptibility to juvenile myoclonic epilepsy and juvenile absence epilepsy. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2010]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30796 | EFHC1 Knockout cell line (HeLa) | Human | EFHC1 | 1:3~1:6 | Negative | Online Inquiry |
KO30797 | EFHC1 Knockout cell line (HCT 116) | Human | EFHC1 | 1:2~1:4 | Negative | Online Inquiry |
KO30798 | EFHC1 Knockout cell line (HEK293) | Human | EFHC1 | 1:3~1:6 | Negative | Online Inquiry |
KO30799 | EFHC1 Knockout cell line (A549) | Human | EFHC1 | 1:3~1:4 | Negative | Online Inquiry |
EFHC1 Gene Knockout Cell Lines are meticulously developed cellular models that facilitate the study of EFHC1 gene functions and their implications in various biological processes. The EFHC1 gene encodes a protein involved in cellular activities such as cell division and response to stress, making it critical for neuronal health and function. Utilizing CRISPR-Cas9 genome editing technology, these cell lines have had the EFHC1 gene precisely eliminated, enabling researchers to investigate the resulting phenotypic changes, molecular pathways, and potential therapeutic targets associated with its loss.
The key function of these knockout cell lines lies in their ability to mimic the genetic absence of EFHC1, providing a powerful tool for examining how its loss influences cellular dynamics, signaling pathways, and the etiology of diseases linked to EFHC1 impairment, such as epilepsy. In both research and clinical settings, these cell lines play an essential role in advancing our understanding of neurobiological disorders, drug discovery, and the development of gene therapies.
What sets these EFHC1 Gene Knockout Cell Lines apart from other biological models is their extraordinary capacity for producing reproducible and consistent data, which is a cornerstone for scientific investigations. Researchers can leverage these cell lines to study specific gene interactions more thoroughly without the confounding effects present in wild-type models. This enhanced specificity allows for the identification of nuanced biological mechanisms and lays the groundwork for innovative treatment strategies.
The value of EFHC1 Gene Knockout Cell Lines extends beyond their functional capabilities; they represent a robust platform for the exploration of new hypotheses in neuroscience and cellular biology, appealing to researchers and clinicians alike. The advanced tools provided for targeted research ensure that users can uncover critical insights that might lead to groundbreaking discoveries.
At [Your Company Name], we pride ourselves on our dedication to excellence in biotechnological innovation, supplying high-quality solutions that empower the scientific community. Our EFHC1 Gene Knockout Cell Lines are engineered with precision to support pivotal research, making them an indispensable asset to laboratories focused on understanding the complexities of genetic regulation in health and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.